The dueling obligations of opioid stewardship

Annals of Internal Medicine

Volumn 160, Issue 3, 2014, Pages 207-208

  Coffin, Phillip ^a   Banta Green, Caleb ^b  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NALOXONE; OPIATE;

ANALGESIA; COST CONTROL; EDITORIAL; FUNCTIONAL STATUS; HEALTH CARE POLICY; HUMAN; LOW BACK PAIN; MAINTENANCE THERAPY; MANAGED CARE ORGANIZATION; MORTALITY; OCCUPATIONAL THERAPY; PAIN; PHYSICIAN; PHYSIOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; DRUG OVERDOSE; GOVERNMENT REGULATION; MEDICAL ETHICS; MEDICAL PRACTICE; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS;

HEALTH POLICY; HUMANS; PHYSICIAN'S ROLE; PRESCRIPTION DRUG MISUSE; SUBSTANCE-RELATED DISORDERS;

EID: 84893856956     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/m13-2781     Document Type: Editorial

References (11)

1. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591-608. [PMID: 23842577]
2. Kirschner N, Ginsburg J, Snyder Sulmasy L. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med. 2014;160:198-200.
3. Institute of Medicine (US) Committee on Advancing Pain Research Care and Education. Care of People with Pain. In: Institute of Medicine (US) Committee on Advancing Pain Research Care and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.. Washington, DC: National Academies Pr; 2011.
4. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85. [PMID: 1633386]
5. Dowell D, Kunins HV, Farley TA. Opioid analgesics-risky drugs, not risky patients. JAMA. 2013;309:2219-20. [PMID: 23700072]
6. McDonald DC, Carlson KE. Estimating the prevalence of opioid diversion by "doctor shoppers" in the United States. PLoS One. 2013;8:e69241. [PMID: 23874923]
7. Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013;8:e54496. [PMID: 23405084]
8. Hickman M, Kimber J, Cornish R, Davoli M, Strang J, Vickerman P, et al. Preventing drug related OD/mortality: Key findings from mortality studies in Europe (UK/Italy). Presented at the College on Problems of Drug Dependence Annual Meeting, 9-14 June 2012, Palm Springs, CA.
9. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013;8: CD004959. [PMID: 23983011]
10. Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, et al. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain. 2013;154:1442-8. [PMID: 23707283]
11. Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. [PMID: 23372174]